019170 — SHINPOONG PHARMACEUTICAL CO Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapFalling Star

Market Cap
KR₩509bn
Enterprise Value
KR₩495bn
Revenue
KR₩235bn

Annual balance sheet for SHINPOONG PHARMACEUTICAL CO, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	92,519	55,795	60,461	56,359	71,495
Net Total Accounts Receivable
Net Total Receivables	90,368	90,718	82,103	72,591	73,528
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	232,997	196,542	198,935	189,321	206,736
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	116,884	113,760	118,638	115,398	108,728
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	398,350	361,536	350,084	342,093	352,466
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	28,550	27,167	76,385	75,844	66,909
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	39,093	31,929	80,498	85,272	82,491
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	359,257	329,607	269,586	256,821	269,975
Total Liabilities & Shareholders' Equity	398,350	361,536	350,084	342,093	352,466
Total Common Shares Outstanding
Total Preferred Shares Outstanding